India's Manipal Health gains as brokerages begin coverage
BUZZ-India's Manipal Health gains as brokerages begin coverage ** Manipal Health's shares MNIA.NS rise as much as 2.75% to 750 rupees
** UBS and J.P. Morgan start coverage of healthcare co at "neutral", Goldman Sachs at "buy"
** 20% CAGR revenue growth over FY2026-2029, ramp-up of new hospitals and improvement in base business mix, industry-leading core margins and best-in-class track-record for turning around acquired hospitals are positive for MNIA - GS
** MNIA's growth outlook supported by steady volume, ramp-up in acquired assets and capacity addition of 2,600 beds by FY2030 - JPM
** UBS also sees industry tailwinds, bed expansion pipeline to aid earnings outlook
** UBS, JPM point to premium valuation for "neutral" rating
** MNIA up 26.3% from IPO price since listing on August 5
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Manipal Health Enterprises
See all newsIndian firms defy stock market slump with record $25 billion half-year equity fundraise
India hospital stocks extend losses on drug pricing concerns; Jefferies sees buying opportunity
India's hospital stocks slide as Supreme Court flags high medicine pricing
Axis initiates coverage of India's Manipal Health with 'buy' on growth, M&A track record
India's Manipal Health gains as brokerages begin coverage